228 related articles for article (PubMed ID: 12964647)
21. [Kidney and hypertension].
Menne J; Fliser D; Haller H
Herz; 2006 Jun; 31(4):317-21. PubMed ID: 16810471
[TBL] [Abstract][Full Text] [Related]
22. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
24. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats.
Ladipo CO; Egbe PE; Ibu JO
Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324
[TBL] [Abstract][Full Text] [Related]
25. Importance of blood pressure control in chronic kidney disease.
Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
[TBL] [Abstract][Full Text] [Related]
26. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
27. Renin inhibition: what are the clinical perspectives?
Hollenberg NK
Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
[TBL] [Abstract][Full Text] [Related]
28. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
Naelten G; Liu KL; Chapuis B; Lo M
Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
[TBL] [Abstract][Full Text] [Related]
29. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
[TBL] [Abstract][Full Text] [Related]
30. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure lowering effects of niacin-bound chromium(III) (NBC) in sucrose-fed rats: renin-angiotensin system.
Perricone NV; Bagchi D; Echard B; Preuss HG
J Inorg Biochem; 2008 Jul; 102(7):1541-8. PubMed ID: 18374418
[TBL] [Abstract][Full Text] [Related]
32. Renin angiotensin system antagonists and anesthesia.
Colson P; Ryckwaert F; Coriat P
Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
[No Abstract] [Full Text] [Related]
33. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
Cofán F; Romero R
Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
[No Abstract] [Full Text] [Related]
34. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
35. AT(1) receptors and control of blood pressure: the kidney and more..
Crowley SD; Gurley SB; Coffman TM
Trends Cardiovasc Med; 2007 Jan; 17(1):30-4. PubMed ID: 17210476
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
37. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
38. Renal hemodynamics in hypertension.
Textor SC
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):24-9. PubMed ID: 3300290
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
40. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
Azizi M
Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
